Pediatric Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot. Platelets stop bleeding by clumping and forming plugs in blood vessel injuries. Thrombocytopenia often occurs as a result of a separate disorder, such as leukemia or an immune system problem.
statistics In the United Kingdom, 1.5% of presentations to a doctor by women aged 16–46 years are for Pediatric thrombocytopenia. Approximately 1 in 60 visits to general practitioners by women < 45 years of age are Pediatric thrombocytopenia related.
Specific treatments for thrombocytopenia will be determined by your child’s physicians based on the cause and severity of the disease, as well as your child’s tolerance for medications, procedures and therapies. Mild cases may not require treatment and may resolve on their own. Blood transfusions with platelets or red blood cells are sometimes needed.
We do clinical treatment studies, most recently centering around rituximab and the thrombopoietic agents as well as studies also exploring the mechanism of Pediatric thrombocytopenia and various markers connected with it. For example, we have looked at the role of different infectious agents (CMV, H Pylori, HIV) in causing ITP, and we have looked at the effects of thrombopoietic agents on the bone marrow and are attempting to relate responses to platelet antibody types.